Influenza A deliberately enhances levels of the human p53 protein to reduce anti-viral gene and protein expression
Genome editing technology is helping A*STAR scientists unravel how the Influenza A virus (IAV) exploits human anti-viral responses.
Nov 30, 2018
0
58
